Results 191 to 200 of about 49,192 (255)

The potential directing role of chemokines for specific metastatic sites in breast cancer. [PDF]

Sci Rep
Ayoub AM, El-Houseini ME, Tharwat E, Bayomy MFF, Abdellateif MS.   +4 more
europepmc   +1 more source

Chemokine CXC motif ligand 12 (CXCL12; SDF-1); CXC chemokine receptor 4 (CXCR4; NPY3R) [PDF]

Science-Business eXchange, 2010
openaire   +1 more source

The Heterogeneity and Function of Stromal Cells in the Tumor Microenvironment. [PDF]

Research (Wash D C)
Wang X, Li S, Xue Y, Liang X, Ma X, Zhang K, Wang Y.   +6 more
europepmc   +1 more source

CXC chemokine receptor 4 (CXCR4; NPY3R); chemokine CXC motif ligand 12 (CXCL12; SDF-1) [PDF]

Science-Business eXchange, 2011
openaire   +1 more source

Chemokines in Pregnancy. [PDF]

Biomolecules
Shevchenko JA, Gizbrekht AA, Sennikov SV.   +2 more
europepmc   +1 more source

ARAP1 fine-tunes F-actin polymerization level in lymphocytes through RhoA inhibition. [PDF]

Front Immunol
Ueda Y, Kondo N, Kamioka Y, Kinashi T.
europepmc   +1 more source

Chemokine CXC motif ligand 12 (CXCL12; SDF-1); CXC chemokine receptor 4 (CXCR4; NPY3R) [PDF]

Science-Business eXchange, 2013
openaire   +1 more source

Human and viral chemokines differentially modulate G protein signaling, β-arrestin recruitment and chemotaxis mediated by the viral G protein-coupled receptor ORF74. [PDF]

Cell Commun Signal
Kong Q, Van Bosstraeten B, Jacquemyn M, Daelemans D, De Jonghe S, Schols D, Van Loy T.   +6 more
europepmc   +1 more source

Chemokines in the resolution of inflammation: key players and targets for therapeutic modulation. [PDF]

Front Immunol
Oliveira VLS, Proost P, Struyf S.
europepmc   +1 more source

Inhibition of constitutive activity of the atypical chemokine receptor 3 by the small-molecule inverse agonist VUF16840. [PDF]

Mol Pharmacol
Bosma R, Nesheva D, Rijnsburger M, Riemens R, Adamska JM, Meyrath M, Mobach S, Buzink CM, van der Pol S, de Esch IJP, Szpakowska M, Wijtmans M, Chevigne A, Vischer HF, Leurs R.   +14 more
europepmc   +1 more source